FDA to Introduce New Validation Errors for Study Data
Oct18

FDA to Introduce New Validation Errors for Study Data

These requirements pertain to submission of clinical and non-clinical data for studies initiated after December 17, 2016 if you’re filing NDAs, BLAs, and ANDAs. For commercial INDs, the requirement starts after December 17, 2017. In the event an original submission was filed before the requirements went into effect, subsequent submissions (amendments, supplements, and reports) to these types of applications still must meet the requirements.

Read More
Health Canada Hints at 2018 eCTD Mandate
Jul21

Health Canada Hints at 2018 eCTD Mandate

In a notice posted to its website, Health Canada gave advance warning that the agency is considering an eCTD filing requirement, or eCTD mandate, that would take effect as early as January 1, 2018. Health Canada is asking for stakeholders to submit comments by August 31, 2016. Comments can be sent to ereview@hc-sc.gc.ca.

Read More
Updated ICH eCTD Specification Sets Requirements for Collapsed Bookmarks, Unique Headers or Footers
Apr08

Updated ICH eCTD Specification Sets Requirements for Collapsed Bookmarks, Unique Headers or Footers

The International Conference on Harmonization recently published a new Specification for Submission Formats for eCTD document. The document achieved ICH step 4 classification, meaning it’s approved for use by all regions. Collapsing bookmarks when documents are opened, a requirement for unique headers or footers on all pages and a limited set of fonts that are recommended for embedding are among the most notable new rules.

Read More
A Look at FDA Submission Metrics for Module 1
Mar18

A Look at FDA Submission Metrics for Module 1

Submissions metrics for the US FDA’s new Module 1 shared with industry at the DIA RSIDM 2016 Forum paint a picture of modest activity for the enhanced specification. As of February 1, 2016, 117 companies submitted a total of 1,639 sequences of varying application and submission types.

Read More
FDA to Answer ESG Submission Surge with Usability Enhancements
Feb16

FDA to Answer ESG Submission Surge with Usability Enhancements

More than 3 million submissions were received via the ESG in 2015, and FDA representatives are estimating 7 million submissions for the year 2016. The volume increase is quite substantial considering 11.3 million submissions passed through the ESG in the previous 10 years (January 2006 to January 2016). Small user improvements planned by the FDA, and announced at DIA RSIDM 2016, will make life easier for sponsors who are growing more dependent on their Gateway accounts.

Read More